TrialJournal of thrombosis and haemostasis : JTH2022

Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa.

B Alexander Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.